These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19048281)

  • 1. Surgical aspects and complications of continuous intraperitoneal insulin infusion with an implantable pump.
    Haveman JW; Logtenberg SJ; Kleefstra N; Groenier KH; Bilo HJ; Blomme AM
    Langenbecks Arch Surg; 2010 Jan; 395(1):65-71. PubMed ID: 19048281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous intraperitoneal insulin infusion in type 1 diabetes: a 6-year post-trial follow-up.
    van Dijk PR; Logtenberg SJ; Groenier KH; Gans RO; Kleefstra N; Bilo HJ
    BMC Endocr Disord; 2014 Apr; 14():30. PubMed ID: 24708696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications of continuous intraperitoneal insulin infusion with an implantable pump.
    van Dijk PR; Logtenberg SJ; Groenier KH; Haveman JW; Kleefstra N; Bilo HJ
    World J Diabetes; 2012 Aug; 3(8):142-8. PubMed ID: 22912916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Report of a 7 year case-control study of continuous intraperitoneal insulin infusion and subcutaneous insulin therapy among patients with poorly controlled type 1 diabetes mellitus: favourable effects on hypoglycaemic episodes.
    van Dijk PR; Logtenberg SJ; Groenier KH; Gans RO; Bilo HJ; Kleefstra N
    Diabetes Res Clin Pract; 2014 Nov; 106(2):256-63. PubMed ID: 25305134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Design of a Percutaneous Port System for Continuous Intraperitoneal Insulin Infusion.
    Rieger C; Kurz K; Mueller-Hoffmann W; Gehr B; Liebl A
    J Diabetes Sci Technol; 2019 Nov; 13(6):1158-1160. PubMed ID: 31195815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A New Optimized Percutaneous Access System for CIPII.
    Garcia-Verdugo R; Erbach M; Schnell O
    J Diabetes Sci Technol; 2017 Jul; 11(4):814-821. PubMed ID: 28654300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous intraperitoneal insulin infusion partly restores the glucagon response to hypoglycaemia in type 1 diabetic patients.
    Oskarsson PR; Lins PE; Backman L; Adamson UC
    Diabetes Metab; 2000 Apr; 26(2):118-24. PubMed ID: 10804326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentre trial of a programmable implantable insulin pump in type I diabetes. The Point Study II Group.
    Int J Artif Organs; 1995 Jun; 18(6):322-5. PubMed ID: 8593967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical experience with implantable insulin pumps. Department of Veterans Affairs Implantable Insulin Pump Study Group.
    Thompson JS; Duckworth WC; Saudek CD; Giobbie-Hurder A
    Am J Surg; 1998 Dec; 176(6):622-6. PubMed ID: 9926802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal insulin infusion improves the depletion in choline-containing phospholipids of lipoprotein B particles in type I diabetic patients.
    Guerci B; Igau B; Ziegler O; Crea T; Fruchart JC; Drouin P; Fievet C
    Metabolism; 1996 Apr; 45(4):430-4. PubMed ID: 8609827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. After 6years of intraperitoneal insulin administration IGF-I concentrations in T1DM patients are at low-normal level.
    van Dijk PR; Logtenberg SJ; Chisalita SI; Hedman CA; Groenier KH; Gans RO; Kleefstra N; Arnqvist HJ; Bilo HJ
    Growth Horm IGF Res; 2015 Dec; 25(6):316-9. PubMed ID: 26336814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin kinetics in type I diabetic patients treated by continuous intraperitoneal insulin infusion: influence of anti-insulin antibodies.
    Lassmann-Vague V; Belicar P; Alessis C; Raccah D; Vialettes B; Vague P
    Diabet Med; 1996 Dec; 13(12):1051-5. PubMed ID: 8973887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable programmable insulin pumps for the treatment of diabetes.
    Waxman K; Turner D; Nguyen ST; Selam JL; Charles MA
    Arch Surg; 1992 Sep; 127(9):1032-6; discussion 1036-7. PubMed ID: 1387526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catheter complications associated with implantable systems for peritoneal insulin delivery. An analysis of frequency, predisposing factors, and obstructing materials.
    Renard E; Baldet P; Picot MC; Jacques-Apostol D; Lauton D; Costalat G; Bringer J; Jaffiol C
    Diabetes Care; 1995 Mar; 18(3):300-6. PubMed ID: 7555471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraperitoneal insulin therapy in patients with type 1 diabetes. Does it fit into the current therapeutic arsenal?
    Giménez M; Purkayajtha S; Moscardó V; Conget I; Oliver N
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Mar; 65(3):182-184. PubMed ID: 29429951
    [No Abstract]   [Full Text] [Related]  

  • 16. Intraperitoneal insulin delivery to patients with type 1 diabetes results in higher serum IGF-I bioactivity than continuous subcutaneous insulin infusion.
    Hedman CA; Frystyk J; Lindström T; Oskarsson P; Arnqvist HJ
    Clin Endocrinol (Oxf); 2014 Jul; 81(1):58-62. PubMed ID: 23865977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological effects of intraperitoneal versus subcutaneous insulin infusion in patients with diabetes mellitus type 1: A systematic review and meta-analysis.
    Dirnena-Fusini I; Åm MK; Fougner AL; Carlsen SM; Christiansen SC
    PLoS One; 2021; 16(4):e0249611. PubMed ID: 33848314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases.
    Allen PJ; Nissan A; Picon AI; Kemeny N; Dudrick P; Ben-Porat L; Espat J; Stojadinovic A; Cohen AM; Fong Y; Paty PB
    J Am Coll Surg; 2005 Jul; 201(1):57-65. PubMed ID: 15978444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy.
    Palmisano P; Accogli M; Zaccaria M; Luzzi G; Nacci F; Anaclerio M; Favale S
    Europace; 2013 Apr; 15(4):531-40. PubMed ID: 23407627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraperitoneal insulin infusion: treatment option for type 1 diabetes resulting in beneficial endocrine effects beyond glycaemia.
    van Dijk PR; Logtenberg SJ; Gans RO; Bilo HJ; Kleefstra N
    Clin Endocrinol (Oxf); 2014 Oct; 81(4):488-97. PubMed ID: 25041605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.